PMID- 35736838 OWN - NLM STAT- MEDLINE DCOM- 20220707 LR - 20230829 IS - 1520-5827 (Electronic) IS - 0743-7463 (Linking) VI - 38 IP - 26 DP - 2022 Jul 5 TI - Interfacial Water in the SARS Spike Protein: Investigating the Interaction with Human ACE2 Receptor and In Vitro Uptake in A549 Cells. PG - 7976-7988 LID - 10.1021/acs.langmuir.2c00671 [doi] AB - The severity of global pandemic due to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has engaged the researchers and clinicians to find the key features triggering the viral infection to lung cells. By utilizing such crucial information, researchers and scientists try to combat the spread of the virus. Here, in this work, we performed in silico analysis of the protein-protein interactions between the receptor-binding domain (RBD) of the viral spike protein and the human angiotensin-converting enzyme 2 (hACE2) receptor to highlight the key alteration that happened from SARS-CoV to SARS-CoV-2. We analyzed and compared the molecular differences between spike proteins of the two viruses using various computational approaches such as binding affinity calculations, computational alanine, and molecular dynamics simulations. The binding affinity calculations showed that SARS-CoV-2 binds a little more firmly to the hACE2 receptor than SARS-CoV. The major finding obtained from molecular dynamics simulations was that the RBD-ACE2 interface is populated with water molecules and interacts strongly with both RBD and ACE2 interfacial residues during the simulation periods. The water-mediated hydrogen bond by the bridge water molecules is crucial for stabilizing the RBD and ACE2 domains. Near-ambient pressure X-ray photoelectron spectroscopy (NAP-XPS) confirmed the presence of vapor and molecular water phases in the protein-protein interfacial domain, further validating the computationally predicted interfacial water molecules. In addition, we examined the role of interfacial water molecules in virus uptake by lung cell A549 by binding and maintaining the RBD/hACE2 complex at varying temperatures using nanourchins coated with spike proteins as pseudoviruses and fluorescence-activated cell sorting (FACS) as a quantitative approach. The structural and dynamical features presented here may serve as a guide for developing new drug molecules, vaccines, or antibodies to combat the COVID-19 pandemic. FAU - Singh, Ajay Vikram AU - Singh AV AUID- ORCID: 0000-0002-9875-7727 AD - Department of Chemical and Product Safety, German Federal Institute for Risk Assessment (BfR), Max-Dohrn-Strasse 8-10, 10589 Berlin, Germany. FAU - Kayal, Abhijit AU - Kayal A AD - Quantumzyme LLP, Bangalore 560027, India. FAU - Malik, Ashish AU - Malik A AUID- ORCID: 0000-0002-7508-9519 AD - Quantumzyme LLP, Bangalore 560027, India. FAU - Maharjan, Romi Singh AU - Maharjan RS AD - Department of Chemical and Product Safety, German Federal Institute for Risk Assessment (BfR), Max-Dohrn-Strasse 8-10, 10589 Berlin, Germany. FAU - Dietrich, Paul AU - Dietrich P AUID- ORCID: 0000-0002-2720-9918 AD - SPECS Surface Nano Analysis GmbH, Voltastrasse 5, 13355 Berlin, Germany. FAU - Thissen, Andreas AU - Thissen A AD - SPECS Surface Nano Analysis GmbH, Voltastrasse 5, 13355 Berlin, Germany. FAU - Siewert, Katherina AU - Siewert K AD - Department of Chemical and Product Safety, German Federal Institute for Risk Assessment (BfR), Max-Dohrn-Strasse 8-10, 10589 Berlin, Germany. FAU - Curato, Caterina AU - Curato C AD - Department of Chemical and Product Safety, German Federal Institute for Risk Assessment (BfR), Max-Dohrn-Strasse 8-10, 10589 Berlin, Germany. FAU - Pande, Kajal AU - Pande K AD - Quantumzyme LLP, Bangalore 560027, India. FAU - Prahlad, Dwarakanath AU - Prahlad D AD - Quantumzyme LLP, Bangalore 560027, India. FAU - Kulkarni, Naveen AU - Kulkarni N AD - Quantumzyme LLP, Bangalore 560027, India. FAU - Laux, Peter AU - Laux P AUID- ORCID: 0000-0002-0351-3392 AD - Department of Chemical and Product Safety, German Federal Institute for Risk Assessment (BfR), Max-Dohrn-Strasse 8-10, 10589 Berlin, Germany. FAU - Luch, Andreas AU - Luch A AD - Department of Chemical and Product Safety, German Federal Institute for Risk Assessment (BfR), Max-Dohrn-Strasse 8-10, 10589 Berlin, Germany. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20220623 PL - United States TA - Langmuir JT - Langmuir : the ACS journal of surfaces and colloids JID - 9882736 RN - 0 (Spike Glycoprotein, Coronavirus) RN - 0 (spike protein, SARS-CoV-2) RN - 059QF0KO0R (Water) RN - EC 3.4.15.1 (Peptidyl-Dipeptidase A) RN - EC 3.4.17.23 (ACE2 protein, human) RN - EC 3.4.17.23 (Angiotensin-Converting Enzyme 2) SB - IM MH - A549 Cells MH - *Angiotensin-Converting Enzyme 2/chemistry/metabolism MH - *COVID-19/metabolism/virology MH - Humans MH - Molecular Dynamics Simulation MH - Pandemics MH - Peptidyl-Dipeptidase A/metabolism MH - Protein Binding MH - SARS-CoV-2/metabolism MH - *Spike Glycoprotein, Coronavirus/chemistry/metabolism MH - *Water/chemistry EDAT- 2022/06/24 06:00 MHDA- 2022/07/08 06:00 CRDT- 2022/06/23 11:02 PHST- 2022/06/24 06:00 [pubmed] PHST- 2022/07/08 06:00 [medline] PHST- 2022/06/23 11:02 [entrez] AID - 10.1021/acs.langmuir.2c00671 [doi] PST - ppublish SO - Langmuir. 2022 Jul 5;38(26):7976-7988. doi: 10.1021/acs.langmuir.2c00671. Epub 2022 Jun 23.